Published in Brachytherapy on September 05, 2009
High-dose-rate brachytherapy boost for prostate cancer: rationale and technique. J Contemp Brachytherapy (2014) 0.86
Localized prostate cancer treated with external beam radiation therapy: Long-term outcomes at a European comprehensive cancer centre. Rep Pract Oncol Radiother (2016) 0.81
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer. Radiat Oncol (2013) 0.79
Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev (2011) 3.63
Does tumor growth follow a "universal law"? J Theor Biol (2003) 2.47
Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst (2011) 2.47
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol (2010) 2.42
Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol (2007) 2.26
Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol (2010) 2.19
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys (2007) 2.02
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol (2009) 1.91
Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 1.63
GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol (2009) 1.60
Radiation exposure after permanent prostate brachytherapy. Radiother Oncol (2006) 1.47
Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol (2006) 1.45
Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol (2008) 1.20
Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol (2003) 1.12
Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol (2010) 1.12
Tracking mycorrhizas and extraradical mycelium of the edible fungus Lactarius deliciosus under field competition with Rhizopogon spp. Mycorrhiza (2008) 1.12
Evaluation of tuberculosis transmission in Tehran: using RFLP and spoligotyping methods. J Infect (2004) 1.10
Evaluation of mycelial inocula of edible Lactarius species for the production of Pinus pinaster and P. sylvestris mycorrhizal seedlings under greenhouse conditions. Mycorrhiza (2003) 1.10
Population dynamics of tuberculous Bacilli in Cameroon as assessed by spoligotyping. J Clin Microbiol (2012) 1.09
Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol (2006) 1.08
Quality indicators in radiotherapy. Radiother Oncol (2007) 1.08
Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. Radiother Oncol (2009) 1.06
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. BJU Int (2012) 1.05
Seasonal dynamics of Boletus edulis and Lactarius deliciosus extraradical mycelium in pine forests of central Spain. Mycorrhiza (2013) 1.04
Molecular and quantitative analysis of metal ion binding to humic acids from sewage sludge and sludge-amended soils by fluorescence spectroscopy. Environ Sci Technol (2006) 1.02
The white book of radiation oncology in Spain. Clin Transl Oncol (2011) 1.00
Radiotherapy capacity in Europe. Lancet Oncol (2013) 1.00
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis (2006) 0.99
Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmol (2013) 0.98
Quantification of extraradical mycelium of Tuber melanosporum in soils from truffle orchards in northern Spain. Mycorrhiza (2012) 0.98
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study. Int J Radiat Oncol Biol Phys (2005) 0.98
Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Surg Oncol (2010) 0.97
Mycorrhizal synthesis between Boletus edulis species complex and rockroses (Cistus sp.). Mycorrhiza (2008) 0.96
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res (2003) 0.96
The role of the radiation oncologist in oncology today. Clin Transl Oncol (2010) 0.94
Molecular identification of the edible ectomycorrhizal fungus Lactarius deliciosus in the symbiotic and extraradical mycelium stages. J Biotechnol (2006) 0.93
Binding of polycyclic aromatic hydrocarbons by humic acids formed during composting. Environ Pollut (2008) 0.92
Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up. Radiother Oncol (2013) 0.92
Overview of brachytherapy resources in Latin America: a patterns-of-care survey. Brachytherapy (2011) 0.92
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol (2010) 0.90
Accessibility as a major determinant of radiotherapy underutilization: a population based study. Health Policy (2006) 0.90
High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol (2009) 0.89
Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med (2010) 0.89
Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis (2004) 0.89
A re-adjustable sling for female recurrent stress incontinence and sphincteric deficiency: Outcomes and complications in 125 patients using the Remeex sling system. Neurourol Urodyn (2010) 0.88
Spanish researchers at the forefront of clinical investigation: the case of quality of life in prostate cancer. Clin Transl Oncol (2009) 0.88
Prevalence of antiretroviral drug resistance among treatment-naive and treated HIV-infected patients in Venezuela. Mem Inst Oswaldo Cruz (2009) 0.88
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study. Tumori (2009) 0.88
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys (2011) 0.87
Laparotomy wound recurrence of endometrial carcinoma. Gynecol Oncol (2003) 0.87
Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy. Clin Transl Oncol (2011) 0.86
Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol (2008) 0.86
Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology (2009) 0.85
Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer. Radiother Oncol (2006) 0.85
Chondrosarcoma of the nasal septum. Eur Arch Otorhinolaryngol (2014) 0.84
Quantification of extraradical soil mycelium and ectomycorrhizas of Boletus edulis in a Scots pine forest with variable sporocarp productivity. Mycorrhiza (2011) 0.84
Mannose-binding lectin gene polymorphisms are associated with gestational diabetes mellitus. J Clin Endocrinol Metab (2004) 0.84
Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study. Transplantation (2010) 0.84
The importance of the White Book of Radiation Oncology. Clin Transl Oncol (2011) 0.84
Detection of copper(II) and zinc(II) binding to humic acids from pig slurry and amended soils by fluorescence spectroscopy. Environ Pollut (2006) 0.84
Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol (2014) 0.83
Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol (2012) 0.83
Brachytherapy in the United Kingdom and Spain: a subset analysis of a European pattern of care survey. Clin Transl Oncol (2009) 0.83
Development and refinement of a technique using a medical radiation therapy facility to irradiate immunodeficient mice bearing xenografted human tumours. Lab Anim (2012) 0.83
Patterns of care for brachytherapy in Europe, in Spain and Italy: comparative results. Tumori (2007) 0.83
Patterns of care for brachytherapy in Europe: facilities and resources in brachytherapy in the European area. Brachytherapy (2008) 0.82
Field persistence of the edible ectomycorrhizal fungus Lactarius deliciosus: effects of inoculation strain, initial colonization level, and site characteristics. Mycorrhiza (2009) 0.82
Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients. Phys Med Biol (2013) 0.82
Metastatic uveal melanoma: is there a role for conventional chemotherapy? - A single center study based on 58 patients. Melanoma Res (2011) 0.82
Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results. J BUON (2015) 0.81
[Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC]. Med Clin (Barc) (2009) 0.81
Clinical and technical feasibility of ultra-boost irradiation in Dominant Intraprostatic Lesion by Tomotherapy: preliminary experience and revision of literature. Panminerva Med (2015) 0.81
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART). Med Oncol (2013) 0.81
Greenhouse evaluation of struvite and sludges from municipal wastewater treatment works as phosphorus sources for plants. J Agric Food Chem (2007) 0.81
Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures. Int J Tuberc Lung Dis (2012) 0.80
Ursolic acid inhibits neointima formation in the rat carotid artery injury model. Atherosclerosis (2006) 0.80
Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities. J Clin Microbiol (2012) 0.80
Organic matter in degraded agricultural soils amended with composted and thermally-dried sewage sludges. Sci Total Environ (2007) 0.80
[Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy]. Gac Sanit (2011) 0.80
The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women. Neurourol Urodyn (2013) 0.80
Quality assurance of a record-and-verify system. Tumori (2009) 0.80
A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family. Breast Cancer Res Treat (2009) 0.79
Irradiation of pacemakers and cardio-defibrillators in patients submitted to radiotherapy: a clinical experience. Tumori (2010) 0.79